Evaluation of Xpert® Carba-R Assay Performance from FecalSwab™ Samples.

IF 3.3 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Diagnostics Pub Date : 2025-02-25 DOI:10.3390/diagnostics15050556
Nicla Giovacchini, Chiara Chilleri, Ilaria Baccani, Eleonora Riccobono, Gian Maria Rossolini, Alberto Antonelli
{"title":"Evaluation of Xpert<sup>®</sup> Carba-R Assay Performance from FecalSwab™ Samples.","authors":"Nicla Giovacchini, Chiara Chilleri, Ilaria Baccani, Eleonora Riccobono, Gian Maria Rossolini, Alberto Antonelli","doi":"10.3390/diagnostics15050556","DOIUrl":null,"url":null,"abstract":"<p><p><b>Background/Objectives</b>: The emergence and spread of carbapenemase-producing <i>Enterobacterales</i> (CPE) represents a significant challenge prompting the need to optimize diagnostic tools to detect CPE carriers. The Xpert<sup>®</sup> Carba-R assay (Cepheid, Sunnyvale, CA, USA), a Real-Time PCR-based test, can detect the <i>bla</i><sub>KPC</sub>, <i>bla</i><sub>VIM</sub>, <i>bla</i><sub>OXA-48</sub>, <i>bla</i><sub>NDM</sub> and <i>bla</i><sub>IMP</sub> carbapenemase genes directly from rectal swabs. This study assessed the performance of the Xpert<sup>®</sup> Carba-R assay using FecalSwab™ (Copan, Brescia, Italy), a liquid-based collection device. <b>Methods</b>: The first part of the study aimed to establish the FecalSwab<sup>TM</sup> volume which gave the most similar Ct values to those obtained by the Transystem™ double swab (Copan). The best volume was then used to assess the limit of detection (LoD) for each target and compare the accuracy of different FecalSwab<sup>TM</sup> storage conditions (room temperature or 4 °C after 16 h compared to T<sub>0</sub>). <b>Results</b>: The results indicated that using 200 µL of the FecalSwab™ medium provided reliable Ct values, with the lowest number of invalid samples compared to traditional methods. The average LoDs for different carbapenemases ranged from 4.7 × 10<sup>3</sup> to 6.8 × 10<sup>3</sup> CFU/mL. FecalSwab™ showed a better performance after 16 h at room temperature compared to storage at 4 °C. <b>Conclusions</b>: This study supports single sampling with the FecalSwab™ medium for both molecular and cultural methods, for the potential optimization of CPE screening.</p>","PeriodicalId":11225,"journal":{"name":"Diagnostics","volume":"15 5","pages":""},"PeriodicalIF":3.3000,"publicationDate":"2025-02-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11898457/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diagnostics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3390/diagnostics15050556","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Background/Objectives: The emergence and spread of carbapenemase-producing Enterobacterales (CPE) represents a significant challenge prompting the need to optimize diagnostic tools to detect CPE carriers. The Xpert® Carba-R assay (Cepheid, Sunnyvale, CA, USA), a Real-Time PCR-based test, can detect the blaKPC, blaVIM, blaOXA-48, blaNDM and blaIMP carbapenemase genes directly from rectal swabs. This study assessed the performance of the Xpert® Carba-R assay using FecalSwab™ (Copan, Brescia, Italy), a liquid-based collection device. Methods: The first part of the study aimed to establish the FecalSwabTM volume which gave the most similar Ct values to those obtained by the Transystem™ double swab (Copan). The best volume was then used to assess the limit of detection (LoD) for each target and compare the accuracy of different FecalSwabTM storage conditions (room temperature or 4 °C after 16 h compared to T0). Results: The results indicated that using 200 µL of the FecalSwab™ medium provided reliable Ct values, with the lowest number of invalid samples compared to traditional methods. The average LoDs for different carbapenemases ranged from 4.7 × 103 to 6.8 × 103 CFU/mL. FecalSwab™ showed a better performance after 16 h at room temperature compared to storage at 4 °C. Conclusions: This study supports single sampling with the FecalSwab™ medium for both molecular and cultural methods, for the potential optimization of CPE screening.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
FecalSwab™样品的Xpert®Carba-R分析性能评估
背景/目的:产碳青霉烯酶肠杆菌(CPE)的出现和传播是一个重大挑战,促使需要优化诊断工具来检测CPE携带者。Xpert®Carba-R检测(Cepheid, Sunnyvale, CA, USA)是一种基于实时pcr的检测方法,可直接从直肠拭子中检测blaKPC、blaVIM、blaxa -48、blaNDM和blaIMP碳青霉烯酶基因。本研究使用FecalSwab™(Copan, Brescia, Italy)液体收集装置评估Xpert®Carba-R测定的性能。方法:研究的第一部分旨在建立FecalSwabTM体积,其Ct值与Transystem™双拭子(Copan)获得的Ct值最相似。然后使用最佳体积评估每个目标的检出限(LoD),并比较不同FecalSwabTM储存条件(室温或4°C后16 h与T0相比)的准确性。结果:结果表明,使用200µL FecalSwab™培养基提供可靠的Ct值,与传统方法相比,无效样品数量最少。不同碳青霉烯酶的平均lod范围为4.7 × 103 ~ 6.8 × 103 CFU/mL。FecalSwab™在室温下保存16小时后表现出比在4℃下保存更好的性能。结论:本研究支持用FecalSwab™培养基进行分子和培养方法的单次取样,以潜在地优化CPE筛选。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Diagnostics
Diagnostics Biochemistry, Genetics and Molecular Biology-Clinical Biochemistry
CiteScore
4.70
自引率
8.30%
发文量
2699
审稿时长
19.64 days
期刊介绍: Diagnostics (ISSN 2075-4418) is an international scholarly open access journal on medical diagnostics. It publishes original research articles, reviews, communications and short notes on the research and development of medical diagnostics. There is no restriction on the length of the papers. Our aim is to encourage scientists to publish their experimental and theoretical research in as much detail as possible. Full experimental and/or methodological details must be provided for research articles.
期刊最新文献
Corneal Toxicity of Mirvetuximab Soravtansine: Multimodal Imaging Features and Implications for Ophthalmologic Management. Meta-Analytic Modeling to Define Decision Thresholds for Cerebrospinal Fluid Heparin-Binding Protein in Healthcare-Associated Ventriculitis and Meningitis. Genetic Disorders Detectable by Fetal MRI: A Review. Preoperative Gadoxetic-Acid-Enhanced MRI Features Associated with Rapid Recurrence (<6 Months) After Curative Resection for Hepatocellular Carcinoma. Investigation of the Prevalence of Associated Genetic Mutations (Co-Mutations) in Patients with Actionable Driver Mutations in Lung Cancer: A Retrospective Study.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1